L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC)
Clinical trial NCT04852172 · TERMINATED
Trial details
- NCT number
- NCT04852172
- Sponsor
- Asklepion Pharmaceuticals, LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-29
- Primary completion
- 2024-02-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.